Carotid Body Removal for the Treatment of Resistant Hypertension
Primary Purpose
Hypertension
Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Carotid body excision
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension
Eligibility Criteria
Inclusion Criteria:
- Age of participants will be 18-75 years
Resistant HTN criteria:
- Daytime mean ambulatory systolic blood pressure ≥135mmHg and office systolic blood pressure ≥150mmHg
- Patients on at least three anti-hypertensive medications, including a diuretic, at maximum tolerated dose
- No evidence of causes for secondary HTN following thorough clinical assessment
- Patient medication concordance will be monitored via medication/blood pressure diary
Exclusion Criteria:
- Calculated GFR <45ml/min/1.73m2
- Carotid body located outside the defined carotid septum
- Obstructive carotid atherosclerotic disease with >50% stenosis
- Oxygen desaturation at rest below 92%
- Known structural lung disease
- Requirement for oxygen therapy to maintain oxygen saturation
- Patients wish to participate in mountain climbing, skin diving or free diving
- Pregnancy or anticipation of pregnancy
- Palliative care/chemotherapy
- Acute coronary syndrome or unstable angina
- Stroke or transient ischaemic attack (TIA) < 6 months prior to procedure
- Expected life expectancy less than 12 months due to other disease
- Intravenous drug use
- Alcohol intake >28 units/week
- Febrile illness within two weeks of participation
- Unable to attend for follow up appointments in Bristol at 1, 3, 6, 12 and 24 months post-operatively.
MR imaging related exclusion criteria (all participants):
- Pace-maker, implantable cardiac defibrillator, cerebral metallic clips or other implanted metal devices/structures
- Unable to tolerate scanner or history of panic attacks/claustrophobia
- Learning disability, significant hearing or visual impairment (participant would need to able to communicate from within the MRI scanner)
Sites / Locations
- Clinical Research and Imaging Centre (CRIC) and the Bristol Heart Institute (BHI), University Hospitals Bristol NHS Foundation Trust
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Carotid body excision
Arm Description
Patients undergoing the carotid body excision to test the hypothesis that carotid body excision is sufficient to attain target blood pressure.
Outcomes
Primary Outcome Measures
Change of Blood Pressure
Change from Baseline Blood Pressure at 3 months
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01745172
Brief Title
Carotid Body Removal for the Treatment of Resistant Hypertension
Official Title
Carotid Body Removal for the Treatment of Chronic Diseases Characterized by Excessive Central Sympathetic Activity Including Resistant Hypertension: a Pilot Study.
Study Type
Interventional
2. Study Status
Record Verification Date
October 2016
Overall Recruitment Status
Completed
Study Start Date
January 2013 (undefined)
Primary Completion Date
May 2016 (Actual)
Study Completion Date
June 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Noblewell
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This is a pilot study to assess the effectiveness, safety and feasibility of carotid body removal in patients with high blood pressure (hypertension) resistant to medical treatment. Patients with high blood pressure are at significant risk of medical complications including stroke and heart disease. The principle research question is whether removal of the carotid body will lead to an improvement in the blood pressure of this patient group.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
4 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Carotid body excision
Arm Type
Experimental
Arm Description
Patients undergoing the carotid body excision to test the hypothesis that carotid body excision is sufficient to attain target blood pressure.
Intervention Type
Procedure
Intervention Name(s)
Carotid body excision
Intervention Description
This surgery does not involve any study drug or investigational device.
The carotid body will be removed by the so called 'lateral approach' or a combined 'lateral and medial approach'. In all cases the target area was defined as the tissue in between the ECA and ICA, up to 5-6mm above the bifurcation point of the common carotid artery into the ECA and ICA. In a lateral approach the carotid bifurcation is not turned. A combined approach includes usually dissection of the superior thyroid vessel and turning of the carotid bifurcation.
Primary Outcome Measure Information:
Title
Change of Blood Pressure
Description
Change from Baseline Blood Pressure at 3 months
Time Frame
Baseline and 3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age of participants will be 18-75 years
Resistant HTN criteria:
Daytime mean ambulatory systolic blood pressure ≥135mmHg and office systolic blood pressure ≥150mmHg
Patients on at least three anti-hypertensive medications, including a diuretic, at maximum tolerated dose
No evidence of causes for secondary HTN following thorough clinical assessment
Patient medication concordance will be monitored via medication/blood pressure diary
Exclusion Criteria:
Calculated GFR <45ml/min/1.73m2
Carotid body located outside the defined carotid septum
Obstructive carotid atherosclerotic disease with >50% stenosis
Oxygen desaturation at rest below 92%
Known structural lung disease
Requirement for oxygen therapy to maintain oxygen saturation
Patients wish to participate in mountain climbing, skin diving or free diving
Pregnancy or anticipation of pregnancy
Palliative care/chemotherapy
Acute coronary syndrome or unstable angina
Stroke or transient ischaemic attack (TIA) < 6 months prior to procedure
Expected life expectancy less than 12 months due to other disease
Intravenous drug use
Alcohol intake >28 units/week
Febrile illness within two weeks of participation
Unable to attend for follow up appointments in Bristol at 1, 3, 6, 12 and 24 months post-operatively.
MR imaging related exclusion criteria (all participants):
Pace-maker, implantable cardiac defibrillator, cerebral metallic clips or other implanted metal devices/structures
Unable to tolerate scanner or history of panic attacks/claustrophobia
Learning disability, significant hearing or visual impairment (participant would need to able to communicate from within the MRI scanner)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paul A. Sobotka, MD
Organizational Affiliation
Cibiem, Inc.
Official's Role
Study Director
Facility Information:
Facility Name
Clinical Research and Imaging Centre (CRIC) and the Bristol Heart Institute (BHI), University Hospitals Bristol NHS Foundation Trust
City
Bristol
ZIP/Postal Code
BS2 8HW
Country
United Kingdom
12. IPD Sharing Statement
Plan to Share IPD
Yes
Learn more about this trial
Carotid Body Removal for the Treatment of Resistant Hypertension
We'll reach out to this number within 24 hrs